Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes

Background: Intra-articular injection of hyaluronan (HA) has been suggested to have a disease-modifying effect in osteoarthritis, but little is known about the possible mechanisms. Objective: To investigate the effects of HA species of different molecular mass, including 800 kDa (HA800) and 2700 kDa (HA2700), on the expression of aggrecanases (ie, ADAMTS species), which play a key role in aggrecan degradation. Methods: The effects of HA species on the expression of ADAMTS1, 4, 5, 8, 9 and 15 in interleukin 1α (IL1α)-stimulated osteoarthritic chondrocytes were studied by reverse transcription PCR and real-time PCR. Expression of ADAMTS4 protein and aggrecanase activity and signal transduction pathways of IL1, CD44 and intracellular adhesion molecule 1 (ICAM1) were examined by immunoblotting. Results: IL1α treatment of chondrocytes induced ADAMTS4, and HA800 and HA2700 significantly decreased IL1α-induced expression of ADAMTS4 mRNA and protein. IL1α-stimulated aggrecanase activity in osteoarthritic chondrocytes was reduced by treatment with HA2700 or transfection of small interfering RNA for ADAMTS4. A similar result was obtained when HA2700 was added to explant cultures of osteoarthritic cartilage. HA2700 neither directly inhibited nor bound to ADAMTS4. Downregulation of ADAMTS4 expression by HA2700 was attenuated by treatment of IL1α-treated chondrocytes with antibodies to CD44 and/or ICAM1. The increased phosphorylation of IL1 receptor-associated kinase-1 and extracellular signal-regulated protein kinase1/2 induced by the IL1α treatment was downregulated by enhanced IRAK-M expression after HA2700 treatment. Conclusion: These data suggest that HA2700 suppresses aggrecan degradation by downregulating IL1α-induced ADAMTS4 expression through the CD44 and ICAM1 signalling pathways in osteoarthritic chondrocytes.

[1]  K. Tanzawa,et al.  Inhibition of ADAMTS4 (aggrecanase‐1) by tissue inhibitors of metalloproteinases (TIMP‐1, 2, 3 and 4) , 2001, FEBS letters.

[2]  H. Ma,et al.  Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis , 2005, Nature.

[3]  Yoshiaki Toyama,et al.  Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. , 2003, The American journal of pathology.

[4]  A. Engström‐Làurent,et al.  Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. , 1985, Annals of the rheumatic diseases.

[5]  Y. Hirasawa,et al.  The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. , 1999, Osteoarthritis and cartilage.

[6]  L. Moreland.  Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action , 2003, Arthritis research & therapy.

[7]  A. Fourie,et al.  ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro , 2005, Nature.

[8]  Gakuji Hashimotoa,et al.  Inhibition of ADAMTS 4 ( aggrecanase-1 ) by tissue inhibitors of metalloproteinases ( TIMP-1 , 2 , 3 and 4 ) , 2001 .

[9]  Y. Okada,et al.  Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3 , 2004, Clinical & Experimental Metastasis.

[10]  R. Moskowitz,et al.  Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. , 1986, Arthritis and rheumatism.

[11]  Takashi Nakamura,et al.  Inhibition of interleukin-1β-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage , 2004 .

[12]  T. Shiomi,et al.  ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3. , 2006, Cancer research.

[13]  M. Akagi,et al.  Possible involvement of the oxidized low-density lipoprotein/lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis. , 2007, Osteoarthritis and cartilage.

[14]  D. Amiel,et al.  The long-term effects of hyaluronan during development of osteoarthritis following partial meniscectomy in a rabbit model. , 2000, Osteoarthritis and cartilage.

[15]  T. Hardingham,et al.  Hyaluronic acid in cartilage and proteoglycan aggregation. , 1974, The Biochemical journal.

[16]  T. Shiomi,et al.  ADAM-12 (meltrin alpha) is involved in chondrocyte proliferation via cleavage of insulin-like growth factor binding protein 5 in osteoarthritic cartilage. , 2008, Arthritis and rheumatism.

[17]  D. Edwards,et al.  The ADAMTS metalloproteinases. , 2005, The Biochemical journal.

[18]  Felipe García,et al.  Tumor Cells Deactivate Human Monocytes by Up-Regulating IL-1 Receptor Associated Kinase-M Expression via CD44 and TLR41 , 2005, The Journal of Immunology.

[19]  E. Ohuchi,et al.  Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. , 2000, Arthritis and rheumatism.

[20]  T. Shiomi,et al.  ADAM 28 Is Overexpressed in Human Breast Carcinomas : Implications for Carcinoma Cell Proliferation through Cleavage of Insulin-like Growth Factor Binding Protein-3 , 2006 .

[21]  内藤 智子,et al.  Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage , 2009 .

[22]  R. Coutts,et al.  The effects of hyaluronan during the development of osteoarthritis. , 1997, Osteoarthritis and cartilage.

[23]  J. Buckwalter,et al.  Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. , 2005, Osteoarthritis and cartilage.

[24]  H. Im,et al.  Hyaluronan Oligosaccharides Induce Matrix Metalloproteinase 13 via Transcriptional Activation of NFκB and p38 MAP Kinase in Articular Chondrocytes* , 2006, Journal of Biological Chemistry.

[25]  M Kashiwagi,et al.  TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)* , 2001, The Journal of Biological Chemistry.

[26]  S. Santavirta,et al.  Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[27]  D. Edwards,et al.  The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. , 2002, Arthritis and rheumatism.

[28]  Hiroshi Asanuma,et al.  Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy , 2002, Nature Medicine.

[29]  R. Maki,et al.  References Subscriptions Permissions Email Alerts Expression and Regulation of Aggrecanase in Arthritis: The Role of TGF- β , 2013 .

[30]  Takashi Nakamura,et al.  Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. , 2004, Arthritis and rheumatism.

[31]  T. Shiomi,et al.  Expression of ADAMTS4 (aggrecanase‐1) in human osteoarthritic cartilage , 2007, Pathology international.

[32]  D. Guidolin,et al.  Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement. , 2001, Arthritis and rheumatism.

[33]  D. Edwards,et al.  Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption , 2005, Arthritis research & therapy.

[34]  R. Cortivo,et al.  The effect of hyaluronan on CD44-mediated survival of normal and hydroxyl radical-damaged chondrocytes. , 2003, Osteoarthritis and cartilage.

[35]  Navin L Rao,et al.  IRAK1: a critical signaling mediator of innate immunity. , 2008, Cellular signalling.

[36]  S. Kumar,et al.  Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments. , 2006, Osteoarthritis and cartilage.

[37]  R. Maki,et al.  Expression and regulation of aggrecanase in arthritis: the role of TGF-beta. , 2002, Journal of immunology.

[38]  P. Chockalingam,et al.  Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2). , 2004, Arthritis and rheumatism.

[39]  S. Goldring,et al.  The role of cytokines in cartilage matrix degeneration in osteoarthritis. , 2004, Clinical orthopaedics and related research.

[40]  D. Zukor,et al.  Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). , 2000, Arthritis and rheumatism.

[41]  A. Rowan,et al.  Oncostatin M in combination with tumour necrosis factor α induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2 , 2005, Annals of the rheumatic diseases.

[42]  T. Shiomi,et al.  Tetraspanin CD151 is expressed in osteoarthritic cartilage and is involved in pericellular activation of pro-matrix metalloproteinase 7 in osteoarthritic chondrocytes. , 2006, Arthritis and rheumatism.

[43]  M. Tortorella,et al.  The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation. , 2001, Osteoarthritis and cartilage.

[44]  D. Griggs,et al.  Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. , 2007, Arthritis and rheumatism.

[45]  Y. Kato,et al.  Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. , 1993, Arthritis and rheumatism.

[46]  B. Chiang,et al.  High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. , 2006, Osteoarthritis and cartilage.

[47]  T. Aigner,et al.  Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. , 2002, Arthritis and rheumatism.

[48]  F. De Ceuninck,et al.  Effects of transforming growth factor-β on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro , 2004 .

[49]  T. Yasuda.  Hyaluronan inhibits cytokine production by lipopolysaccharide-stimulated U937 macrophages through down-regulation of NF-κB via ICAM-1 , 2007, Inflammation Research.

[50]  R. Copeland,et al.  Aggrecan Protects Cartilage Collagen from Proteolytic Cleavage* , 2003, Journal of Biological Chemistry.

[51]  G. Prestwich,et al.  Regulation of lung injury and repair by Toll-like receptors and hyaluronan , 2005, Nature Medicine.

[52]  T. Kubo,et al.  Long-term effects of hyaluronan on experimental osteoarthritis in the rabbit knee. , 1998, Osteoarthritis and cartilage.

[53]  Y. Okada,et al.  ADAMTS4 (Aggrecanase-1) Interaction with the C-terminal Domain of Fibronectin Inhibits Proteolysis of Aggrecan* , 2004, Journal of Biological Chemistry.